Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Uric acid as a marker for renal dysfunction in hypertensive women on diuretic and nondiuretic therapy.

Borges RL, Hirota AH, Quinto BM, Ribeiro AB, Zanella MT, Batista MC.

J Clin Hypertens (Greenwich). 2009 May;11(5):253-9.

PMID:
19534022
2.

Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.

See LC, Kuo CF, Chuang FH, Li HY, Chen YM, Chen HW, Yu KH.

J Rheumatol. 2009 Aug;36(8):1691-8. doi: 10.3899/jrheum.081199. Epub 2009 Jun 16.

PMID:
19531754
3.

Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients.

Park JT, Kim DK, Chang TI, Kim HW, Chang JH, Park SY, Kim E, Kang SW, Han DS, Yoo TH.

Nephrol Dial Transplant. 2009 Nov;24(11):3520-5. doi: 10.1093/ndt/gfp272. Epub 2009 Jun 2.

PMID:
19491381
4.

Uric acid and long-term outcomes in CKD.

Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, Collins AJ, Levey AS, Menon V.

Am J Kidney Dis. 2009 May;53(5):796-803. doi: 10.1053/j.ajkd.2008.12.021. Epub 2009 Mar 20.

5.

A preliminary investigation of the association between serum uric acid and impaired renal function.

Chen YC, Su CT, Wang ST, Lee HD, Lin SY.

Chang Gung Med J. 2009 Jan-Feb;32(1):66-71.

6.

Risk factors for end-stage renal disease: 25-year follow-up.

Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS.

Arch Intern Med. 2009 Feb 23;169(4):342-50. doi: 10.1001/archinternmed.2008.605.

7.

Community-based study on CKD subjects and the associated risk factors.

Chen N, Wang W, Huang Y, Shen P, Pei D, Yu H, Shi H, Zhang Q, Xu J, Lv Y, Fan Q.

Nephrol Dial Transplant. 2009 Jul;24(7):2117-23. doi: 10.1093/ndt/gfn767. Epub 2009 Feb 4.

8.

Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?

Johnson RJ, Perez-Pozo SE, Sautin YY, Manitius J, Sanchez-Lozada LG, Feig DI, Shafiu M, Segal M, Glassock RJ, Shimada M, Roncal C, Nakagawa T.

Endocr Rev. 2009 Feb;30(1):96-116. doi: 10.1210/er.2008-0033. Epub 2009 Jan 16. Review.

9.

Uric acid and cardiovascular risk.

Feig DI, Kang DH, Johnson RJ.

N Engl J Med. 2008 Oct 23;359(17):1811-21. doi: 10.1056/NEJMra0800885. Review. No abstract available. Erratum in: N Engl J Med. 2010 Jun 10;362(23):2235.

10.

Elevated uric acid increases the risk for kidney disease.

Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R.

J Am Soc Nephrol. 2008 Dec;19(12):2407-13. doi: 10.1681/ASN.2008010080. Epub 2008 Sep 17.

11.

Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.

Feig DI, Soletsky B, Johnson RJ.

JAMA. 2008 Aug 27;300(8):924-32. doi: 10.1001/jama.300.8.924.

12.

Effect of febuxostat on the progression of renal disease in 5/6 nephrectomy rats with and without hyperuricemia.

Sánchez-Lozada LG, Tapia E, Soto V, Avila-Casado C, Franco M, Wessale JL, Zhao L, Johnson RJ.

Nephron Physiol. 2008;108(4):p69-78. doi: 10.1159/000127837. Epub 2008 Apr 24.

PMID:
18434753
13.

Uric acid and incident kidney disease in the community.

Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS.

J Am Soc Nephrol. 2008 Jun;19(6):1204-11. doi: 10.1681/ASN.2007101075. Epub 2008 Mar 12.

14.

Pathogenesis of essential hypertension: historical paradigms and modern insights.

Johnson RJ, Feig DI, Nakagawa T, Sanchez-Lozada LG, Rodriguez-Iturbe B.

J Hypertens. 2008 Mar;26(3):381-91. doi: 10.1097/HJH.0b013e3282f29876. Review.

15.

Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.

Sturm G, Kollerits B, Neyer U, Ritz E, Kronenberg F; MMKD Study Group.

Exp Gerontol. 2008 Apr;43(4):347-52. doi: 10.1016/j.exger.2008.01.006. Epub 2008 Jan 26.

PMID:
18294794
16.

Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system.

Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML.

J Hypertens. 2008 Feb;26(2):269-75. doi: 10.1097/HJH.0b013e3282f240bf.

PMID:
18192841
17.

Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions.

Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N, Uz E, Akcay A, Yigitoglu R, Covic A.

Int Urol Nephrol. 2007;39(4):1227-33. Epub 2007 Aug 15.

PMID:
17701281
18.

Relationship of uric acid with progression of kidney disease.

Chonchol M, Shlipak MG, Katz R, Sarnak MJ, Newman AB, Siscovick DS, Kestenbaum B, Carney JK, Fried LF.

Am J Kidney Dis. 2007 Aug;50(2):239-47.

PMID:
17660025
19.

J-shaped mortality relationship for uric acid in CKD.

Suliman ME, Johnson RJ, García-López E, Qureshi AR, Molinaei H, Carrero JJ, Heimbürger O, Bárány P, Axelsson J, Lindholm B, Stenvinkel P.

Am J Kidney Dis. 2006 Nov;48(5):761-71.

PMID:
17059995
20.

Uric acid and hypertension.

Feig DI, Kang DH, Nakagawa T, Mazzali M, Johnson RJ.

Curr Hypertens Rep. 2006 May;8(2):111-5. Review.

PMID:
16672142

Supplemental Content

Support Center